Close

Arena Pharmaceuticals, Inc. (ARNA) Tops Q2 EPS by 3c

August 1, 2013 7:45 AM EDT Send to a Friend
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reported Q2 EPS of $0.18, $0.03 better than the analyst estimate of $0.15. Revenue for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login